International Clinical Trial: DHATUSARATA ASSESSMENT ON TYPE 2 DIABETES MELLITUS

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117117) titled 'DHATUSARATA ASSESSMENT ON TYPE 2 DIABETES MELLITUS' on Sept. 7.

Study Type: Observational

Study Design: Randomized, Parallel Group Trial Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable

Primary Sponsor: Dr KamalBasha A

Condition: Health Condition 1: E119- Type 2 diabetes mellitus without complications

Intervention: Intervention1: Nil: Nil Intervention2: Nil: Nil

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 08-01-2027

Target Sample Size: 272

Countries of Recruitment: Ind...